Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
Dexcom (DXCM) G6 CGM System Gets Public Coverage From Ontario
12:02pm, Monday, 14'th Mar 2022
Dexcom's (DXCM) G6 CGM System can help people with type 1 diabetes over two years of age through the coverage announced by the Ontario government.
Dexcom glucose monitoring system for managing diabetes gets CE Mark in Europe
08:52am, Monday, 14'th Mar 2022 Seeking Alpha
DexCom (DXCM) said it secured CE Mark (Conformité Européenne) for the Dexcom G7 Continuous Glucose Monitoring ((CGM)) system for people with diabetes in Europe age two years and…
Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management
07:30am, Monday, 14'th Mar 2022 Business Wire
EDINBURGH, Scotland & SAN DIEGO--(BUSINESS WIRE)---- $DXCM #CGM--Dexcom G7 Receives CE Mark – Next Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management
DexCom to Take Its Technology International
11:00am, Sunday, 13'th Mar 2022 The Motley Fool
Investors should keep this healthcare stock on their radar.
DexCom to Take Its Technology International
07:00am, Sunday, 13'th Mar 2022
Investors should keep this healthcare stock on their radar.
Got $5,000? 3 Growth Stocks to Buy That Could Double Your Money
10:45am, Saturday, 12'th Mar 2022
They have a whole lot going right, and little in the way of obstacles.
IHI: A Standout Performer With Equally Strong Future Growth Prospects
05:42am, Saturday, 05'th Mar 2022 Kwhen FinanceIHI: A Standout Performer With Equally Strong Future Growth Prospects
12:42am, Saturday, 05'th Mar 2022
IHI: A Standout Performer With Equally Strong Future Growth Prospects
Dexcom's (DXCM) CGM Gets FDA's Breakthrough Device Designation
01:49pm, Friday, 04'th Mar 2022
Dexcom's (DXCM) CGM's use in the hospital setting is likely to be more effective in glycemic management and improved patient outcomes.
Dexcom wins FDA brekathrough nod for use of its CGM in hospitals
02:19pm, Wednesday, 02'nd Mar 2022 Drug Delivery Business
Dexcom (NSDQ:DXCM) announced that it received FDA breakthrough device designation for the use of its CGM in the hospital setting. The Dexcom continuous glucose monitor (CGM) uses a small, wearable sensor and transmitter to continuously measure and send glucose levels wirelessly to a smart device to provide real-time glucose data and eliminate the need for […] The post Dexcom wins FDA brekathrough nod for use of its CGM in hospitals appeared first on Drug Delivery Business .
DexCom''s Glucose Monitoring System Snags Breakthrough Device Tag For Hospital Use
11:24am, Wednesday, 02'nd Mar 2022 Benzinga
The FDA granted Breakthrough Device Designation for DexCom Inc (NASDAQ: DXCM ) for continuous glucose monitoring (CGM) use in the hospital setting. Dexcom CGM uses a small, wearable sensor and transmitter to continuously measure and send glucose levels wirelessly to a smart device, providing real-time glucose data … Full story available on Benzinga.com
DexCom gets FDA''s breakthrough device designation for Dexcom CGM use in hospital setting
09:57pm, Tuesday, 01'st Mar 2022 Seeking Alpha
DexCom (DXCM) said the U.S. FDA granted Breakthrough Device Designation for Dexcom CGM use in the hospital setting.Dexcom CGM uses a small, wearable sensor and transmitter to…
Up 700%, DexCom Stock Still Has Tons of Room To Run
12:45pm, Sunday, 27'th Feb 2022 The Motley Fool
The market for its products is huge.
Up 700%, DexCom Stock Still Has Tons of Room To Run
07:45am, Sunday, 27'th Feb 2022
The market for its products is huge.
Here’s Why Artisan Partners Trimmed its DexCom (DXCM) Position
08:31am, Friday, 25'th Feb 2022 Insider Monkey
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ fourth quarter 2021 investor letter – a copy of which can be downloaded here.
